 | • レポートコード：QYR9N7723 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、奇病のグローバル市場について調査・分析したレポートで、種類別（自己免疫疾患、遺伝性疾患、血液疾患、がん、成長障害、その他）、用途別（病院と診療所、研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・奇病の世界市場規模 ・主要企業別市場シェア ・奇病の世界市場規模：種類別（自己免疫疾患、遺伝性疾患、血液疾患、がん、成長障害、その他） ・奇病の世界市場規模：用途別（病院と診療所、研究所） ・奇病のアメリカ市場規模（種類別、用途別） ・奇病のヨーロッパ市場規模（種類別、用途別） ・奇病の中国市場規模（種類別、用途別） ・奇病の日本市場規模（種類別、用途別） ・奇病の東南アジア市場規模（種類別、用途別） ・奇病のインド市場規模（種類別、用途別） ・奇病の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・奇病の世界市場予測（2019年-2025年） ・奇病の地域別市場予測（2019年-2025年） ... |
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig’s disease, and Tourette’s syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or “gigantism.” Some diseases have patient populations of fewer than a hundred.New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
In 2018, the global Orphan Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Orphan Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orphan Diseases development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie
Market segment by Type, the product can be split into
Autoimmune Disorders
Genetic Disorders
Blood Disorders
Cancer
Growth Disorder
Cardiovascular Diseases
Neurological Disorders
Respiratory Disorders
Digestive Disorders
Eye Disorders
Market segment by Application, split into
Hospitals And Clinics
Research Laboratories
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Orphan Diseases status, future forecast, growth opportunity, key market and key players.
To present the Orphan Diseases development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Orphan Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Orphan Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Autoimmune Disorders
1.4.3 Genetic Disorders
1.4.4 Blood Disorders
1.4.5 Cancer
1.4.6 Growth Disorder
1.4.7 Cardiovascular Diseases
1.4.8 Neurological Disorders
1.4.9 Respiratory Disorders
1.4.10 Digestive Disorders
1.4.11 Eye Disorders
1.5 Market by Application
1.5.1 Global Orphan Diseases Market Share by Application (2014-2025)
1.5.2 Hospitals And Clinics
1.5.3 Research Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Orphan Diseases Market Size
2.2 Orphan Diseases Growth Trends by Regions
2.2.1 Orphan Diseases Market Size by Regions (2014-2025)
2.2.2 Orphan Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Orphan Diseases Market Size by Manufacturers
3.1.1 Global Orphan Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Orphan Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Orphan Diseases Key Players Head office and Area Served
3.3 Key Players Orphan Diseases Product/Solution/Service
3.4 Date of Enter into Orphan Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Orphan Diseases Market Size by Type (2014-2019)
4.2 Global Orphan Diseases Market Size by Application (2014-2019)
5 United States
5.1 United States Orphan Diseases Market Size (2014-2019)
5.2 Orphan Diseases Key Players in United States
5.3 United States Orphan Diseases Market Size by Type
5.4 United States Orphan Diseases Market Size by Application
6 Europe
6.1 Europe Orphan Diseases Market Size (2014-2019)
6.2 Orphan Diseases Key Players in Europe
6.3 Europe Orphan Diseases Market Size by Type
6.4 Europe Orphan Diseases Market Size by Application
7 China
7.1 China Orphan Diseases Market Size (2014-2019)
7.2 Orphan Diseases Key Players in China
7.3 China Orphan Diseases Market Size by Type
7.4 China Orphan Diseases Market Size by Application
8 Japan
8.1 Japan Orphan Diseases Market Size (2014-2019)
8.2 Orphan Diseases Key Players in Japan
8.3 Japan Orphan Diseases Market Size by Type
8.4 Japan Orphan Diseases Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Orphan Diseases Market Size (2014-2019)
9.2 Orphan Diseases Key Players in Southeast Asia
9.3 Southeast Asia Orphan Diseases Market Size by Type
9.4 Southeast Asia Orphan Diseases Market Size by Application
10 India
10.1 India Orphan Diseases Market Size (2014-2019)
10.2 Orphan Diseases Key Players in India
10.3 India Orphan Diseases Market Size by Type
10.4 India Orphan Diseases Market Size by Application
11 Central & South America
11.1 Central & South America Orphan Diseases Market Size (2014-2019)
11.2 Orphan Diseases Key Players in Central & South America
11.3 Central & South America Orphan Diseases Market Size by Type
11.4 Central & South America Orphan Diseases Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Orphan Diseases Introduction
12.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Orphan Diseases Introduction
12.2.4 Novartis Revenue in Orphan Diseases Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Orphan Diseases Introduction
12.3.4 Celgene Revenue in Orphan Diseases Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Orphan Diseases Introduction
12.4.4 Roche Revenue in Orphan Diseases Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Orphan Diseases Introduction
12.5.4 Pfizer Revenue in Orphan Diseases Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Alexion
12.6.1 Alexion Company Details
12.6.2 Company Description and Business Overview
12.6.3 Orphan Diseases Introduction
12.6.4 Alexion Revenue in Orphan Diseases Business (2014-2019)
12.6.5 Alexion Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Orphan Diseases Introduction
12.7.4 Sanofi Revenue in Orphan Diseases Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Vertex Pharmaceuticals
12.8.1 Vertex Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Orphan Diseases Introduction
12.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2014-2019)
12.8.5 Vertex Pharmaceuticals Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Orphan Diseases Introduction
12.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2014-2019)
12.9.5 GlaxoSmithKline Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Orphan Diseases Introduction
12.10.4 Merck Revenue in Orphan Diseases Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Abbvie
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Orphan Diseases Key Market Segments
Table Key Players Orphan Diseases Covered
Table Global Orphan Diseases Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Orphan Diseases Market Size Market Share by Type 2014-2025
Figure Autoimmune Disorders Figures
Table Key Players of Autoimmune Disorders
Figure Genetic Disorders Figures
Table Key Players of Genetic Disorders
Figure Blood Disorders Figures
Table Key Players of Blood Disorders
Figure Cancer Figures
Table Key Players of Cancer
Figure Growth Disorder Figures
Table Key Players of Growth Disorder
Figure Cardiovascular Diseases Figures
Table Key Players of Cardiovascular Diseases
Figure Neurological Disorders Figures
Table Key Players of Neurological Disorders
Figure Respiratory Disorders Figures
Table Key Players of Respiratory Disorders
Figure Digestive Disorders Figures
Table Key Players of Digestive Disorders
Figure Eye Disorders Figures
Table Key Players of Eye Disorders
Table Global Orphan Diseases Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals And Clinics Case Studies
Figure Research Laboratories Case Studies
Figure Orphan Diseases Report Years Considered
Table Global Orphan Diseases Market Size 2014-2025 (Million US$)
Figure Global Orphan Diseases Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Orphan Diseases Market Size by Regions 2014-2025 (Million US$)
Table Global Orphan Diseases Market Size by Regions 2014-2019 (Million US$)
Table Global Orphan Diseases Market Share by Regions 2014-2019
Figure Global Orphan Diseases Market Share by Regions 2014-2019
Figure Global Orphan Diseases Market Share by Regions 2019
Table Market Top Trends
Table Global Orphan Diseases Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Orphan Diseases Market Share by Manufacturers (2014-2019)
Figure Global Orphan Diseases Market Share by Manufacturers in 2018
Table Global Orphan Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Orphan Diseases Product/Solution/Service
Table Date of Enter into Orphan Diseases Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table Global Orphan Diseases Market Size Share by Type (2014-2019)
Figure Global Orphan Diseases Market Size Market Share by Type (2014-2019)
Table Global Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table Global Orphan Diseases Market Size Share by Application (2014-2019)
Figure Global Orphan Diseases Market Size Market Share by Application (2014-2019)
Figure Global Orphan Diseases Revenue Market Share by Application in 2018
Figure United States Orphan Diseases Market Size 2014-2019 (Million US$)
Table United States Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table United States Key Players Orphan Diseases Market Share (2018-2019)
Table United States Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table United States Orphan Diseases Market Share by Type (2014-2019)
Table United States Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table United States Orphan Diseases Market Share by Application (2014-2019)
Figure Europe Orphan Diseases Market Size 2014-2019 (Million US$)
Table Europe Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table Europe Key Players Orphan Diseases Market Share (2018-2019)
Table Europe Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table Europe Orphan Diseases Market Share by Type (2014-2019)
Table Europe Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table Europe Orphan Diseases Market Share by Application (2014-2019)
Figure China Orphan Diseases Market Size 2014-2019 (Million US$)
Table China Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table China Key Players Orphan Diseases Market Share (2018-2019)
Table China Orphan Diseases Market Size by Type (2014-20189) (Million US$)
Table China Orphan Diseases Market Share by Type (2014-2019)
Table China Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table China Orphan Diseases Market Share by Application (2014-2019)
Figure Japan Orphan Diseases Market Size 2014-2019 (Million US$)
Table Japan Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table Japan Key Players Orphan Diseases Market Share (2018-2019)
Table Japan Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table Japan Orphan Diseases Market Share by Type (2014-2019)
Table Japan Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table Japan Orphan Diseases Market Share by Application (2014-2019)
Figure Southeast Asia Orphan Diseases Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Orphan Diseases Market Share (2018-2019)
Table Southeast Asia Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Orphan Diseases Market Share by Type (2014-2019)
Table Southeast Asia Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Orphan Diseases Market Share by Application (2014-2019)
Figure India Orphan Diseases Market Size 2014-2019 (Million US$)
Table India Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table India Key Players Orphan Diseases Market Share (2018-2019)
Table India Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table India Orphan Diseases Market Share by Type (2014-2019)
Table India Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table India Orphan Diseases Market Share by Application (2014-2019)
Figure Central & South America Orphan Diseases Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Orphan Diseases Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Orphan Diseases Market Share (2018-2019)
Table Central & South America Orphan Diseases Market Size by Type (2014-2019) (Million US$)
Table Central & South America Orphan Diseases Market Share by Type (2014-2019)
Table Central & South America Orphan Diseases Market Size by Application (2014-2019) (Million US$)
Table Central & South America Orphan Diseases Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Orphan Diseases Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Novartis Recent Development
Table Celgene Company Details
Table Celgene Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Celgene Recent Development
Table Roche Company Details
Table Roche Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Pfizer Recent Development
Table Alexion Company Details
Table Alexion Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Alexion Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Alexion Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Sanofi Recent Development
Table Vertex Pharmaceuticals Company Details
Table Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Vertex Pharmaceuticals Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Vertex Pharmaceuticals Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Orphan Diseases Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Orphan Diseases Business (2014-2019)
Table Merck Recent Development
Table Abbvie Company Details
Table Global Orphan Diseases Market Size by Regions (Million US$) 2019-2025
Figure Global Orphan Diseases Market Size Share by Regions (2019-2025)
Figure Global Orphan Diseases Market Size Share by Regions in 2025
Figure United States Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Europe Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure China Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Japan Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure India Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Orphan Diseases Market Size Forecast (2019-2025)(Million USD)
Table Global Orphan Diseases Market Size by Product (2019-2025) (Million US$)
Figure Global Orphan Diseases Market Size by Product (2019-2025)
Figure Global Orphan Diseases Market Size by Product in 2025
Table Global Orphan Diseases Market Size by Application (2019-2025) (Million US$)
Figure Global Orphan Diseases Market Size by Application (2019-2025)
Figure Global Orphan Diseases Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の精神神経疾患および治療市場：市場規模・現状・予測 Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…- 世界の遺伝性疾患薬市場2019 The global Genetic Disorders Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Genetic Disorders Drug market status and forecast, categorizes the global Genetic Disorders Drug market size…
- 世界のパニック障害市場：市場規模・現状・予測 Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used incl…
- 世界の破壊的行動障害（DBD）市場：市場規模・現状・予測 Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO an…
- 世界の副甲状腺疾患市場：市場規模・現状・予測 Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hyp…